InVivo Therapeutics Corporation Appoints Lou Vaickus, MD as Interim Chief Medical Officer
Published: Oct 11, 2013
InVivo Therapeutics Holdings Corp. (NVIV), a drug delivery company with a focus on technologies for the treatment of spinal cord injuries (SCI) and neurotrauma conditions, today announced that Lou Vaickus, MD has been appointed as interim Chief Medical Officer (CMO), effective October 15, 2013, for a period of one year.
Help employers find you! Check out all the jobs and post your resume.